CATALOGO DEI PRODOTTI DELLA RICERCA

ORSOLINI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.861
NA - Nord America 3.157
AS - Asia 2.351
SA - Sud America 351
AF - Africa 47
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.778
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.079
RU - Federazione Russa 1.758
CN - Cina 886
SG - Singapore 871
GB - Regno Unito 630
IT - Italia 324
BR - Brasile 282
DE - Germania 270
SE - Svezia 217
FR - Francia 202
HK - Hong Kong 202
IE - Irlanda 187
VN - Vietnam 117
FI - Finlandia 100
IN - India 65
KR - Corea 56
JP - Giappone 53
CA - Canada 44
UA - Ucraina 33
PL - Polonia 26
AR - Argentina 25
AT - Austria 24
MX - Messico 23
ES - Italia 22
NL - Olanda 18
BE - Belgio 17
TR - Turchia 16
ZA - Sudafrica 15
BD - Bangladesh 14
ID - Indonesia 14
CL - Cile 9
TG - Togo 9
CO - Colombia 8
IR - Iran 8
PY - Paraguay 8
VE - Venezuela 8
UZ - Uzbekistan 7
AZ - Azerbaigian 6
EC - Ecuador 6
IQ - Iraq 6
AU - Australia 5
BJ - Benin 5
MA - Marocco 5
RO - Romania 5
CZ - Repubblica Ceca 4
EG - Egitto 4
GR - Grecia 4
AM - Armenia 3
IL - Israele 3
KG - Kirghizistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
LT - Lituania 2
MK - Macedonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CD - Congo 1
CH - Svizzera 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MN - Mongolia 1
MW - Malawi 1
MY - Malesia 1
PA - Panama 1
PF - Polinesia Francese 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
Totale 9.773
Salva come PNG Salva come JPEG
Città #
Moscow 630
Southend 555
Chandler 478
Dallas 401
Singapore 352
Ashburn 278
Hong Kong 200
Dublin 187
Beijing 159
Jacksonville 136
Redmond 134
New York 98
Ann Arbor 94
Los Angeles 79
Bologna 70
Lawrence 70
Princeton 70
Wilmington 68
Woodbridge 66
Helsinki 55
Shenyang 54
Munich 53
Jinan 50
Tokyo 50
Nanjing 44
Verona 44
Ho Chi Minh City 42
The Dalles 39
Redondo Beach 37
Tianjin 35
Hebei 34
Houston 34
Buffalo 32
Denver 31
Sindelfingen 30
São Paulo 30
Milan 29
Zhengzhou 27
Haikou 25
Ningbo 25
Hangzhou 24
Changsha 23
Columbus 21
Taiyuan 21
Brooklyn 20
Hanoi 20
Seattle 20
Warsaw 20
Chicago 19
Guangzhou 19
Hyderabad 19
London 19
Santa Clara 18
Vienna 18
Montreal 17
Brussels 16
Falkenstein 16
Washington 16
Nanchang 15
San Francisco 15
Taizhou 15
Turku 15
Norwalk 14
Phoenix 14
Poplar 14
Redwood City 14
Jiaxing 13
Atlanta 12
Johannesburg 12
Orem 12
Venice 12
Dong Ket 11
Fuzhou 11
Boston 10
Fairfield 10
Lomé 9
Manchester 9
Mexico City 9
Rio de Janeiro 9
Seoul 9
Chennai 8
Jakarta 8
Toronto 8
Kent 7
Rome 7
Tashkent 7
Baku 6
Belo Horizonte 6
Boardman 6
Cagliari 6
Charlotte 6
Düsseldorf 6
Falls Church 6
Frankfurt am Main 6
Mumbai 6
Shanghai 6
Stockholm 6
Asunción 5
Buenos Aires 5
Calgary 5
Totale 5.661
Salva come PNG Salva come JPEG
Nome #
Artrite Reumatoide e Metabolismo Minerale 241
Anti-CCP antibodies and bone 202
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 197
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 188
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 188
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 184
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 180
Bone involvement and osteoporosis in mastocytosis. 171
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 170
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 168
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 158
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 157
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 156
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 156
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 153
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 151
Osteoporosis treatment: why ibandronic acid? 147
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 145
BIOMARKERS LABORATORISTICI RELATIVI AL COINVOLGIMENTO OSSEO NELLE ARTROPATIE INFIAMMATORIE 144
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 144
Bone Disease in Mastocytosis 143
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 140
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 138
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 135
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 134
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 133
Cardiovascular morbidity and mortality in patients with rheumatic disease: hyperuricemia, a forgotten puzzle piece? 133
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 133
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 133
Association between environmental air pollution and rheumatoid arthritis flares 133
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 132
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 130
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 128
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 125
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 124
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 123
Rheumatoid arthritis, γδ T cells and bisphosphonates 120
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 120
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 120
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 117
Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy. 116
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 116
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 115
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 115
Osteoporosis in Rheumatic Diseases 115
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 113
High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis 112
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 109
Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients? 105
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 105
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 104
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 104
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 103
Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients 102
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 102
Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study 101
Changes in bone turnover markers and bone modulators during abatacept treatment 100
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction 99
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 93
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 93
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 93
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 93
Immunoglobulin G4-Related Disease Responder Index Correlates With the Risk of 1-Year Relapse in Type 1 Autoimmune Pancreatitis 92
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 90
Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus 90
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 89
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 87
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 86
Incidence and predictors of new onset left ventricular diastolic dysfunction in asymptomatic patients with rheumatoid arthritis without overt cardiac disease 83
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 81
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 80
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 78
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 72
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature 70
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 68
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 68
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 65
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 64
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 64
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement 62
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 59
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 57
Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study 53
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 43
Prevalence and determinants of vertebral fractures in a SLE cohort 37
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 25
Totale 9.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.789
article - articoli 36.372
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 417
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.578
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021249 0 0 0 0 0 53 28 8 44 3 68 45
2021/2022602 56 166 10 40 23 8 19 27 58 10 40 145
2022/20231.332 83 147 105 246 120 311 18 66 167 11 46 12
2023/2024757 32 60 70 90 77 146 30 40 13 26 134 39
2024/20251.710 82 103 77 285 90 50 76 68 265 152 140 322
2025/20263.571 368 286 376 973 1.530 38 0 0 0 0 0 0
Totale 9.965